InventisBio (SH:688382) Xin Lang Cai Jing·2025-09-23 06:37Group 1 - Yifang Biotechnology's stock price fell by 5.04% on September 23, closing at 32.01 yuan per share, with a trading volume of 376 million yuan and a turnover rate of 2.70%, resulting in a total market capitalization of 18.512 billion yuan [1] - The stock has experienced a continuous decline for six days, with a cumulative drop of 7.59% during this period [1] - Yifang Biotechnology, established on January 11, 2013, and listed on July 25, 2022, focuses on the research, production, and sales of innovative drugs, with 100% of its main business revenue derived from technology licensing and cooperation [1] Group 2 - Pengyang Fund holds a significant position in Yifang Biotechnology, with its Pengyang Medical Health Mixed A Fund (018052) owning 137,900 shares, accounting for 6.6% of the fund's net value, making it the second-largest holding [2] - The fund has incurred a floating loss of approximately 234,500 yuan today and a total floating loss of 382,100 yuan during the six-day decline [2] - The Pengyang Medical Health Mixed A Fund was established on October 31, 2023, with a latest scale of 22.571 million yuan, achieving a year-to-date return of 54.44% and a one-year return of 59.89% [2]